BioNanoMedicine in Combating Cancer

Event Details

Oslo Cancer Cluster invites you to the symposium “BioNanoMedicine in Combating Cancer”. Advances in nanotechnology and nanomedicine have significantly influenced diagnostic and therapeutic options in oncology and the whole health industry is undergoing substantial changes. This symposium will focus on the recent developments, difficulties and breakthroughs as well as emerging and future trends of the converging fields of nanotechnology, biotechnology and medicine.

This symposium includes a networking session focusing on Horizon 2020 funding opportunities for both academia and industry in the fields of oncology, personalised medicine and nanotechnology. The networking session also offers to the participants the opportunity to discuss new collaborative projects.

This symposium is supported by

For sponsorship opportunities and other queries, connect to (or)


There is no cost attend this event. Please register by completing the form at the end of this page.

Draft Agenda

Moderator of the day: Gupta Udatha (Oslo Cancer Cluster)

10:15–10:20 Welcome and Introduction

Gupta Udatha, Oslo Cancer Cluster, Norway

10:20–10:50 Smart Cancer Nanomedicine

Prof. Twan Lammers, RWTH Aachen University, Germany

10:50–11:20 Nanoparticles for Clinical Use: Importance of Degradation and Excretion

Dr. Tore Skotland, The Norwegian Radium Hospital, Norway

11:20–11:50 Targeted and Nano Therapies in Ovarian Cancer

Dr. Flavio Rizzolio, Ca’ Foscari University of Venice, Italy

11:50–12:30 LUNCH BREAK
12:30–13:00 Why Specialized Characterization is Crucial – Nanomedicines Towards the Clinic

Dr. Ruth Schmid-Baumberger, SINTEF, Norway

13:00–13:30 Ultrasound-Mediated Delivery of Nanoparticles to Tumors

Prof. Catharina de Lange Davies, Norwegian University of Science and Technology, Norway

13:30–14:00 H-Ferritin: A Theranostic Bionanoplatform for Advanced Imaging and Therapy of Solid Tumors

Prof. Davide Prosperi, NanoBioLab, University of Milano Bicocca, Italy

14:00–14:20 COFFEE BREAK


Developing an Innovative Strategy for the Synthesis of Colloidally Stable Nanoconjugates for Cancer Targeting

Dr. Rany Rotem, Marie Curie ITN Fellow, University of Milano Bicocca, Italy

14:50–15:20 Horizon 2020 – Upcoming Calls & Funding Opportunities

Dr. Cecilie Anita Mathiesen & NCPs, The Research Council of Norway, Norway


Dr. Gupta Udatha, Oslo Cancer Cluster, Norway